CRP and Kawasaki disease: As shown in Supplementary Fig. 11, the results are encouraging in that the top selected codes include the highly important laboratory tests for monitoring COVID progression (e.g., D-dimer, CRP, Ferritin) and medications for managing COVID patients (e.g., norepinephrine often used as first-line vasoactive, cefepime for managing bacteria pneumonia complications, tocilizumab, dexamethasone, and remdesivir) as well as related diagnoses and complications (e.g., viral pneumonia, respiratory insufficiency, shock, and kawasaki disease).